home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Soluble Decoys Blunt Pathogenic T Cells

 
  March, 2 2002 2:20
your information resource in human molecular genetics
 
     
Juvenile diabetes can result when cells of the immune system recognize and attack the pancreas. A report in the April issue of Nature Immunology shows how specific “decoys” can subvert the initial activation process by the autoreactive immune cells and block the subsequent tissue damage.

Using a model system of diabetes where the targeted self-protein, as well as the identity of the pathogenic T cells, are known, Sofia Casares and colleagues at the Mount Sinai School of Medicine developed soluble decoy molecules (DEF) that mimicked the normal cellular antigen presentation of peptides to T cells. However, T cells binding to DEF were not activated, as they normally are by peptides, but instead were made “tolerant” of this peptide. This situation led to the development of regulatory T cells that produce cytokines that inhibit pathogenic T cells from killing their targets. Importantly, soluble DEF treatment not only blocked the development of diabetes, but also could treat recent-onset disease in their experimental system, by restoring normal glucose control.

Long-term protection from diabetes was achieved by periodic administration of DEF. Thus, armed with specific knowledge of the pathogenic immune cell target and the identity of the responding cells, these experiments show the feasibility of immunospecific therapies for diabetes and possibly other autoimmune diseases.

Author contact:

Sofia Casares
Mount Sinai School of Medicine
New York, NY
USA
Tel: +1 212 241 9777
E-mail: casars01@doc.mssm.edu

Additional contact for comment on paper:

George S. Eisenbarth
University of Colorado Health Sciences Center
Denver, CO
USA
Tel: +1 303 315 4891
E-mail: george.eisenbarth@uchsc.edu

Also available as an Advanced Online Publication.

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.